RE:RE:RE:RE:RE:RE:RE:Final day to load before Aristotle? TrippingAgain2 wrote: You and Jonny with your crazy insane short position theories can be put to rest hopefully. Shorters dont focus on tiny minature companies with no exposure like SZLS usually. I would just hope SZLS has anything relevant to show for Aristotle.
Remember even though they broke records with there over 1 million in revenue last Q, the market didn't care at all. They may look over good results agian believing Covid will be done by year end. Covid is a short term solution which aslo saved this company luckily last year in january when they were ar 2 cents with nothing to show. SZLS's TOTAL and COMPLETE focus should be on cancer if they want a future in my opinion.
I just can't wait to see what Stage has to show. My popcorn is ready and my eyes are glued. If a miracle happends and its a good rollout with decent product, I myself will invest at a higher price im fine with that, but I put this at like 10% chance of actually happening. 90% chance of blood. GL.
For the first time you actually make a point or two thats worthy of consideration - congrats as there might yet be a glimmer of hope there! However, SZ is already focussed on cancer - however they can`t ignore covid revenue and a cash cow which can finance Aristotle.